Pfizer Inc. today confirmed that it has made a renewed approach to AstraZeneca on a takeover bid valued at nearly $100 billion, the Wall Street Journal reports. Separately, Forest Laboratories has agreed to acquire Furiex Pharmaceuticals in a deal worth up to $1.33 billion.

For reprint and licensing requests for this article, CLICK HERE.